NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
06/23/2026
Back to search
Official data from USPTO
SUTRO
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
43
Latest update
06/23/2026
Trademark type
Combined
Nice classes
5, 40, 42
Filing date
03/24/2023
Registration date
06/23/2026
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/23/2026
Last transaction
06/23/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
07/05/2017
First use in commerce
07/05/2017
Drawing code
3
Owner type
03
Owner location
South San Francisco, CA, US
Examiner
IN, SUNG HYUN
Law office
L30
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the word "SUTRO" with the letter "O" displayed as an elongated crescent with a circle placed in the open portion of the crescent.
Holders and representatives
Holders
Sutro Biopharma, Inc.
Representatives
Karen Won MINTZ, LEVIN, COHN, FERRIS, GLOVSKY, AND POPEO P.C
Technical classification
Nice Classes
Class 5Class 40Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical and biological preparations for the immune system targeting immuno-oncology pathways; Pharmaceutical and biological preparations for use in oncology; Pharmaceuticals and biological preparations for prophylacticdiagnostictherapeutic use in treatingpreventingmanaging cancer; Therapeutic agents for medical useproteins and derivativesantibody-drug conjugatesimmunostimulatory anti-drug conjugatescytokinesbispecific antibodiesengineered antibodies for destroying tumor cells and stimulating immune response; Vaccines; Bacterial lysate preparations and bacterial extract preparationsfor use in the cell free production of therapeutic proteins and peptides for medical use
Class 40
Custom manufacturing of pharmaceuticals and therapeutic agents for medical use; Custom manufacturing of bacterial lysate preparations and bacterial extract preparations
Class 42
Research and development in the fields of pharmaceuticalsbiologicschemistryprotein engineeringproteins and derivativesantibody-drug conjugatesimmunostimulatory anti-drug conjugatescytokinesbispecific antibodiesengineered antibodiesoncologyimmunology; Providing medical scientific research information in the fields of pharmaceuticalsbiologicschemistryprotein engineeringproteins and derivativesantibody-drug conjugatesimmunostimulatory anti-drug conjugatescytokinesbispecific antibodiesengineered antibodiesoncologyimmunology; Drug discoverycustom designdevelopment services featuring therapeutic agents for the treatment and prevention of diseases
Publications
History of USPTO decisions and trademark events.
43 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
06/23/2026
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
05/29/2026
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
05/29/2026
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/05/2026
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/05/2026
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/04/2026
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
02/03/2026
GNRT
NON-FINAL ACTION E-MAILED
02/03/2026
CNRT
SU - NON-FINAL ACTION - WRITTEN
02/03/2026
EEXT
SOU TEAS EXTENSION RECEIVED
01/13/2026
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
01/05/2026
SUPC
STATEMENT OF USE PROCESSING COMPLETE
01/02/2026
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
07/02/2025
EX2G
SOU EXTENSION 2 GRANTED
07/02/2025
IUAF
USE AMENDMENT FILED
07/01/2025
EISU
TEAS STATEMENT OF USE RECEIVED
07/01/2025
EXT2
SOU EXTENSION 2 FILED
07/01/2025
EEXT
SOU TEAS EXTENSION RECEIVED
07/01/2025
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
03/03/2025
EX1G
SOU EXTENSION 1 GRANTED
01/16/2025
EXT1
SOU EXTENSION 1 FILED
01/15/2025
EEXT
SOU TEAS EXTENSION RECEIVED
01/15/2025
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
07/16/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/21/2024
PUBO
PUBLISHED FOR OPPOSITION
05/21/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/01/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/17/2024
XAEC
EXAMINER'S AMENDMENT ENTERED
04/17/2024
ALIE
ASSIGNED TO LIE
04/17/2024
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
04/16/2024
GNEA
EXAMINERS AMENDMENT E-MAILED
04/16/2024
CNEA
EXAMINERS AMENDMENT -WRITTEN
04/16/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/19/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/19/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/19/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
12/20/2023
GNRT
NON-FINAL ACTION E-MAILED
12/20/2023
CNRT
NON-FINAL ACTION WRITTEN
12/20/2023
DOCK
ASSIGNED TO EXAMINER
12/19/2023
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
04/18/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/16/2023
NWAP
NEW APPLICATION ENTERED
03/28/2023
Continuous trademark protection
Get notified about every new filing that threatens SUTRO or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.